Cell-type-specific repression by methyl-CpG-binding protein 2 is biased toward long genes

Journal of Neuroscience

Volumn 34, Issue 38, 2014, Pages 12877-12883

  Sugino, Ken ^a   Hempel, Chris M ^a   Okaty, Benjamin W ^a   Arnson, Hannah A ^a   Kato, Saori ^a   Dani, Vardhan S ^a   Nelson, Sacha B ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

Cell adhesion; MeCP2; Microarray; Rett syndrome

Indexed keywords

COMPLEMENTARY DNA; METHYL CPG BINDING PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL COMMUNICATION AND CELL CONTACT; CELL SELECTION; CELL TYPE; CONTROLLED STUDY; DNA METABOLISM; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENE REPRESSION; GENETIC TRANSCRIPTION; HYBRIDIZATION; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETT SYNDROME; RNA METABOLISM; UPREGULATION; ANIMAL; ANTIBODY SPECIFICITY; CELL COMMUNICATION; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETICS; KNOCKOUT MOUSE; MECP2; METABOLISM; MICROARRAY; NERVE CELL; TRANSGENIC MOUSE;

CELL ADHESION; MECP2; MICROARRAY; RETT SYNDROME;

ANIMALS; CELL ADHESION; CELL COMMUNICATION; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION PROFILING; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; RETT SYNDROME;

EID: 84907150594     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2674-14.2014     Document Type: Article

References (49)

1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185-188. CrossRef Medline
2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25:25-29. CrossRef Medline
3. Belichenko PV, Dahlström A (1995) Confocal laser scanning microscopy and 3-D reconstructions of neuronal structures in human brain cortex. Neuroimage 2:201-207. CrossRef Medline
4. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289-300.
5. Betancur C, Sakurai T, Buxbaum JD (2009) The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends Neurosci 32:402-412. CrossRef Medline
6. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320:1224-1229. CrossRef Medline
7. Chao HT, Zoghbi HY, Rosenmund C (2007) MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56:58-65. CrossRef Medline
8. Chattopadhyaya B, Di Cristo G, Higashiyama H, Knott GW, Kuhlman SJ, Welker E, Huang ZJ (2004) Experience and activity-dependent maturation of perisomatic GABAergic innervation in primary visual cortex during a postnatal critical period. J Neurosci 24:9598-9611. CrossRef Medline
9. Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27:327-331. CrossRef Medline
10. Cohen S, Gabel HW, Hemberg M, Hutchinson AN, Sadacca LA, Ebert DH, Harmin DA, Greenberg RS, Verdine VK, Zhou Z, Wetsel WC, West AE, Greenberg ME (2011) Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function. Neuron 72:72-85. CrossRef Medline
11. Dani VS, Nelson SB (2009) Intact long-term potentiation but reduced connectivity between neocortical layer 5 pyramidal neurons in a mouse model of Rett syndrome. J Neurosci 29:11263-11270. CrossRef Medline
12. Dani VS, Chang Q, Maffei A, Turrigiano GG, Jaenisch R, Nelson SB (2005) Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci USA102:12560-12565.CrossRefMedline
13. Dougherty JD, Geschwind DH (2005) Progress in realizing the promise of microarrays in systems neurobiology. Neuron 45:183-185. CrossRef Medline
14. Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, Nerbonne JM, Lichtman JW, Sanes JR (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28:41-51. CrossRef Medline
15. Fisher RA (1948) Combining independent tests of significance. Am Statistician 2:30.
16. Francke U (2006) Mechanisms of disease: neurogenetics of MeCP2 deficiency. Nat Clin Pract Neurol 2:212-221. CrossRef Medline
17. Giacometti E, Luikenhuis S, Beard C, Jaenisch R (2007) Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci USA 104:1931-1936.CrossRefMedline
18. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, Zhang H, Estes A, Brune CW, Bradfield JP, Imielinski M, Frackelton EC, Reichert J, Crawford EL, Munson J, Sleiman PM, Chiavacci R, Annaiah K, Thomas K, Hou C, et al. (2009) Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459:569-573. CrossRef Medline
19. Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322-326. CrossRef Medline
20. Guy J, Gan J, Selfridge J, Cobb S, Bird A (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315:1143-1147. CrossRef Medline
21. Hempel CM, Sugino K, Nelson SB (2007) A manual method for the purification of fluorescently labeled neurons from the mammalian brain. Nat Protoc 2:2924-2929. CrossRef Medline
22. Jordan C, Li HH, Kwan HC, Francke U (2007) Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med Genet 8:36. CrossRef Medline
23. King IF, Yandava CN, Mabb AM, Hsiao JS, Huang HS, Pearson BL, Calabrese JM, Starmer J, Parker JS, Magnuson T, Chamberlain SJ, Philpot BD, Zylka MJ (2013) Topoisomerases facilitate transcription of long genes linked to autism. Nature 501:58-62. CrossRef Medline
24. Luikenhuis S, Giacometti E, Beard CF, Jaenisch R (2004) Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc Natl Acad Sci U S A 101:6033-6038. CrossRef Medline
25. Lyst MJ, Ekiert R, Ebert DH, Merusi C, Nowak J, Selfridge J, Guy J, Kastan NR, Robinson ND, de Lima Alves F, Rappsilber J, Greenberg ME, Bird A (2013) Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/ SMRT co-repressor. Nat Neurosci 16:898-902. CrossRef Medline
26. Matsushita N, Okada H, Yasoshima Y, Takahashi K, Kiuchi K, Kobayashi K (2002) Dynamics of tyrosine hydroxylase promoter activity during midbrain dopaminergic neuron development. J Neurochem 82:295-304. CrossRef Medline
27. McCall MN, Bolstad BM, Irizarry RA (2010) Frozen robust multiarray analysis (fRMA). Biostatistics 11:242-253. CrossRef Medline
28. Medrihan L, Tantalaki E, Aramuni G, Sargsyan V, Dudanova I, Missler M, Zhang W (2008) Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J Neurophysiol 99:112-121. CrossRef Medline
29. Moretti P, Levenson JM, Battaglia F, Atkinson R, Teague R, Antalffy B, Armstrong D, Arancio O, Sweatt JD, Zoghbi HY (2006) Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome. J Neurosci 26:319-327. CrossRef Medline
30. Nan X, Campoy FJ, Bird A (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88:471-481. CrossRef Medline
31. Nelson ED, Kavalali ET, Monteggia LM (2006) MeCP2-dependent transcriptional repression regulates excitatory neurotransmission. Curr Biol 16:710-716. CrossRef Medline
32. Nelson ED, Kavalali ET, Monteggia LM (2008) Activity-dependent suppression of miniature neurotransmission through the regulation of DNA methylation. J Neurosci 28:395-406. CrossRef Medline
33. Nielsen JB, Bertelsen A, Lou HC (1992) Low CSF HVA levels in the Rett syndrome: a reflection of restricted synapse formation? Brain Dev 14:S63-S65. Medline
34. Nuber UA, Kriaucionis S, Roloff TC, Guy J, Selfridge J, Steinhoff C, Schulz R, Lipkowitz B, Ropers HH, Holmes MC, Bird A (2005) Upregulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum Mol Genet 14:2247-2256. CrossRef Medline
35. Oldfors A, Sourander P, Armstrong DL, Percy AK, Witt-Engerström I, Hagberg BA (1990) Rett syndrome: cerebellar pathology. Pediatr Neurol 6:310-314. CrossRef Medline
36. Pardo CA, Eberhart CG (2007) The neurobiology of autism. Brain Pathol 17:434-447. CrossRef Medline
37. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates. New York: Academic.
38. Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY (2002) Insight into Rett syndrome: MeCP2 levels display tissue-and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11:115-124. CrossRef Medline
39. Skene PJ, Illingworth RS, Webb S, Kerr AR, James KD, Turner DJ, Andrews R, Bird AP (2010) Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. Mol Cell 37:457-468. CrossRef Medline
40. Sugino K, Hempel CM, Miller MN, Hattox AM, Shapiro P, Wu C, Huang ZJ, Nelson SB (2006) Molecular taxonomy of major neuronal classes in the adult mouse forebrain. Nat Neurosci 9:99-107. CrossRef Medline
41. Taneja P, Ogier M, Brooks-Harris G, Schmid DA, Katz DM, Nelson SB (2009) Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome. J Neurosci 29:12187-12195. CrossRef Medline
42. Tudor M, Akbarian S, Chen RZ, Jaenisch R (2002) Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc Natl Acad Sci U S A 99:15536-15541. CrossRef Medline
43. Viemari JC, Roux JC, Tryba AK, Saywell V, Burnet H, Peña F, Zanella S, Bévengut M, Barthelemy-Requin M, Herzing LB, Moncla A, Mancini J, Ramirez JM, Villard L, Hilaire G (2005) Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J Neurosci 25:11521-11530. CrossRef Medline
44. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, Salyakina D, Imielinski M, Bradfield JP, Sleiman PM, Kim CE, Hou C, Frackelton E, Chiavacci R, Takahashi N, Sakurai T, Rappaport E, Lajonchere CM, Munson J, Estes A, et al. (2009) Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459:528-533. CrossRef Medline
45. Yang X, Hou D, Jiang W, Zhang C (2014) Intercellular protein-protein in-teractions at synapses. Protein Cell 5:420-444. CrossRef Medline
46. Ye H, Liu J, Wu JY (2010) Cell adhesion molecules and their involvement in autism spectrum disorder. Neuro Signals 18:62-71. CrossRef Medline
47. Young JI, Hong EP, Castle JC, Crespo-Barreto J, Bowman AB, Rose MF, Kang D, Richman R, Johnson JM, Berget S, Zoghbi HY (2005) Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc Natl Acad Sci U S A 102:17551-17558. CrossRef Medline
48. Zhou Z, Hong EJ, Cohen S, Zhao WN, Ho HY, Schmidt L, Chen WG, Lin Y, Savner E, Griffith EC, Hu L, Steen JA, Weitz CJ, Greenberg ME (2006) Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52: 255-269. CrossRef Medline
49. Zoghbi HY (2003) Postnatal neurodevelopmental disorders: meeting at the synapse? Science 302:826-830. CrossRef Medline